News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SFDA Proposes Further Reforms in China's Drug Approval Process


3/4/2013 10:55:43 AM

by Richard Daverman, PhD

March 1, 2013 -- With the goal of encouraging innovation in both new drugs and generics, the SFDA has released new proposed guidelines for its drug review process. The most significant change will be a new emphasis on the clinical need for the drug. Drugs that address an unmet need – whether new or generic – will be given greater priority. In addition, the SFDA proposes greater emphasis on drugs for children and better protection for clinical trial participants. The SFDA aims to speed up approval for the products that meet the most critical needs. More details....


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES